Covid-19Biden Releases a New Plan to Combat COVID, but Experts Say There's Still a Ways to Go
Both signs of progress and setbacks have cropped up along the way.
Revenue CycleMGMA Asks HHS to Delay No Surprises Act Implementation, Enforcement
It also says that group practices shouldn't be required to obtain information about out-of-network plans.
Covid-19HHS Extends COVID-19 PHE Another 90 Days
HHS has promised to give states at least 60-days notice before lifting the PHE, which allows among other things waivers...
StrategyAs Congress Wrestles With Plans to Expand Medicare, Becerra Says Any One Will Do
Becerra also said he will support efforts to bring down drug prices, including allowing importation from such countries as Canada...
StrategyOIG Cites CMS for Poor Risk Assessments
"CMS?s ERM process did not consider national security risks for any of CMS?s programs in accordance with federal requirements," the...
StrategyBiden Order Pushes Competition, Targets Healthcare Consolidation, High Drug Costs
The executive order targets four areas "where lack of competition in healthcare increases prices and reduces access to quality care"...
StrategyAHA, 340B Health Applaud SCOTUS Decision to Hear Medicare Cuts Case
The AHA applauded the Supreme Court's announcement in a statement released Friday morning.
StrategyCalifornia Lawmakers Push Feds to Allow a Therapy That Pays Meth Users to Abstain
Providers worry that by paying patients they'll violate anti-kickback regulations and thus jeopardize their federal funding through Medicaid.
PayerHHS Unveils Interim Final Rule for Surprise Billing
The Requirements Related to Surprise Billing; Part I , set to take effect on January 1, 2022, is the first...
PayerAHA 'Disappointed' SCOTUS Won't Hear Site-Neutral Appeal
The suit was in response to the 2018 site-neutral final rule that paid hospitals the same reimbursement for some inpatient...
StrategySCOTUS Upholds ACA in California v. Texas Case
In a 7-2 decision, the Court ruled that the plaintiffs do not have standing to sue over the landmark healthcare...
PayerOIG: Medicare Advantage Overpaid Anthem $3.5M
Anthem disputed the findings and rejected the recommendations in its rebuttal of the report.